Based on the results of this randomized trial, the investigators suggest that further study of recombinant human granulocyte colony-stimulating factor is warranted. Medscape Medical News 2003
Leer más en Medscape
C/ San Pedro de Mezonzo nº 39-41
15701 – Santiago de Compostela
Teléfono: +34 986 417 374
Email: secretaria@sogacot.org
Coordinador del Portal y Responsable de Contenidos: Dr. Alejandro González- Carreró Sixto